nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.065	0.0735	CbGbCtD
Praziquantel—CYP3A7—Tamoxifen—pancreatic cancer	0.065	0.0735	CbGbCtD
Praziquantel—CYP3A7—Irinotecan—pancreatic cancer	0.0499	0.0565	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0499	0.0565	CbGbCtD
Praziquantel—CYP3A5—Tamoxifen—pancreatic cancer	0.0487	0.0552	CbGbCtD
Praziquantel—CYP1A2—Dacarbazine—pancreatic cancer	0.0456	0.0516	CbGbCtD
Praziquantel—CYP3A5—Erlotinib—pancreatic cancer	0.0414	0.0469	CbGbCtD
Praziquantel—CYP2C19—Tamoxifen—pancreatic cancer	0.0393	0.0445	CbGbCtD
Praziquantel—CYP3A5—Irinotecan—pancreatic cancer	0.0374	0.0424	CbGbCtD
Praziquantel—CYP3A7—Docetaxel—pancreatic cancer	0.0366	0.0414	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0366	0.0414	CbGbCtD
Praziquantel—CYP3A7—Sunitinib—pancreatic cancer	0.0364	0.0412	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0364	0.0412	CbGbCtD
Praziquantel—CYP1A2—Tamoxifen—pancreatic cancer	0.0363	0.041	CbGbCtD
Praziquantel—CYP1A2—Erlotinib—pancreatic cancer	0.0308	0.0349	CbGbCtD
Praziquantel—CYP2D6—Tamoxifen—pancreatic cancer	0.0299	0.0338	CbGbCtD
Praziquantel—CYP3A5—Docetaxel—pancreatic cancer	0.0274	0.031	CbGbCtD
Praziquantel—CYP3A5—Sunitinib—pancreatic cancer	0.0273	0.0309	CbGbCtD
Praziquantel—CYP1A2—Fluorouracil—pancreatic cancer	0.0267	0.0302	CbGbCtD
Praziquantel—CYP2D6—Erlotinib—pancreatic cancer	0.0254	0.0288	CbGbCtD
Praziquantel—CYP3A4—Tamoxifen—pancreatic cancer	0.019	0.0215	CbGbCtD
Praziquantel—CYP3A4—Erlotinib—pancreatic cancer	0.0162	0.0183	CbGbCtD
Praziquantel—CYP3A4—Irinotecan—pancreatic cancer	0.0146	0.0165	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—pancreatic cancer	0.0125	0.0142	CbGbCtD
Praziquantel—CYP3A4—Docetaxel—pancreatic cancer	0.0107	0.0121	CbGbCtD
Praziquantel—CYP3A4—Sunitinib—pancreatic cancer	0.0106	0.012	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—pancreatic cancer	0.00797	0.00902	CbGbCtD
Praziquantel—Arrhythmia—Tamoxifen—pancreatic cancer	0.000928	0.00796	CcSEcCtD
Praziquantel—Arrhythmia—Erlotinib—pancreatic cancer	0.000918	0.00788	CcSEcCtD
Praziquantel—Bradycardia—Sunitinib—pancreatic cancer	0.000906	0.00777	CcSEcCtD
Praziquantel—Eosinophilia—Fluorouracil—pancreatic cancer	0.000868	0.00745	CcSEcCtD
Praziquantel—Cardiac disorder—Sunitinib—pancreatic cancer	0.000826	0.00708	CcSEcCtD
Praziquantel—Immune system disorder—Sunitinib—pancreatic cancer	0.000804	0.00689	CcSEcCtD
Praziquantel—Arrhythmia—Sunitinib—pancreatic cancer	0.000795	0.00682	CcSEcCtD
Praziquantel—Myalgia—Tamoxifen—pancreatic cancer	0.00077	0.0066	CcSEcCtD
Praziquantel—Myalgia—Erlotinib—pancreatic cancer	0.000762	0.00653	CcSEcCtD
Praziquantel—Discomfort—Tamoxifen—pancreatic cancer	0.000761	0.00652	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000756	0.00649	CcSEcCtD
Praziquantel—Bone disorder—Epirubicin—pancreatic cancer	0.000753	0.00646	CcSEcCtD
Praziquantel—Bradycardia—Irinotecan—pancreatic cancer	0.000746	0.0064	CcSEcCtD
Praziquantel—Nervous system disorder—Erlotinib—pancreatic cancer	0.000716	0.00614	CcSEcCtD
Praziquantel—Skin disorder—Erlotinib—pancreatic cancer	0.000709	0.00608	CcSEcCtD
Praziquantel—Anorexia—Tamoxifen—pancreatic cancer	0.000703	0.00603	CcSEcCtD
Praziquantel—Atrioventricular block—Epirubicin—pancreatic cancer	0.000701	0.00602	CcSEcCtD
Praziquantel—Bone disorder—Doxorubicin—pancreatic cancer	0.000697	0.00598	CcSEcCtD
Praziquantel—Anorexia—Erlotinib—pancreatic cancer	0.000696	0.00597	CcSEcCtD
Praziquantel—Cardiac disorder—Irinotecan—pancreatic cancer	0.00068	0.00583	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000672	0.00577	CcSEcCtD
Praziquantel—Convulsion—Sunitinib—pancreatic cancer	0.000671	0.00576	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000665	0.00571	CcSEcCtD
Praziquantel—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000662	0.00568	CcSEcCtD
Praziquantel—Immune system disorder—Irinotecan—pancreatic cancer	0.000662	0.00568	CcSEcCtD
Praziquantel—Myalgia—Sunitinib—pancreatic cancer	0.000659	0.00566	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000655	0.00562	CcSEcCtD
Praziquantel—Arrhythmia—Irinotecan—pancreatic cancer	0.000655	0.00562	CcSEcCtD
Praziquantel—Atrioventricular block—Doxorubicin—pancreatic cancer	0.000649	0.00557	CcSEcCtD
Praziquantel—Immune system disorder—Gemcitabine—pancreatic cancer	0.000645	0.00553	CcSEcCtD
Praziquantel—Decreased appetite—Tamoxifen—pancreatic cancer	0.000641	0.0055	CcSEcCtD
Praziquantel—Arrhythmia—Gemcitabine—pancreatic cancer	0.000638	0.00547	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000637	0.00547	CcSEcCtD
Praziquantel—Fatigue—Tamoxifen—pancreatic cancer	0.000636	0.00546	CcSEcCtD
Praziquantel—Decreased appetite—Erlotinib—pancreatic cancer	0.000635	0.00544	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00063	0.00541	CcSEcCtD
Praziquantel—Fatigue—Erlotinib—pancreatic cancer	0.000629	0.0054	CcSEcCtD
Praziquantel—Arrhythmia—Fluorouracil—pancreatic cancer	0.000627	0.00538	CcSEcCtD
Praziquantel—Nervous system disorder—Sunitinib—pancreatic cancer	0.00062	0.00532	CcSEcCtD
Praziquantel—Skin disorder—Sunitinib—pancreatic cancer	0.000614	0.00527	CcSEcCtD
Praziquantel—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000603	0.00518	CcSEcCtD
Praziquantel—Anorexia—Sunitinib—pancreatic cancer	0.000602	0.00517	CcSEcCtD
Praziquantel—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000597	0.00512	CcSEcCtD
Praziquantel—Ill-defined disorder—Irinotecan—pancreatic cancer	0.000592	0.00508	CcSEcCtD
Praziquantel—Urticaria—Tamoxifen—pancreatic cancer	0.000586	0.00503	CcSEcCtD
Praziquantel—Abdominal pain—Tamoxifen—pancreatic cancer	0.000583	0.005	CcSEcCtD
Praziquantel—Abdominal pain—Erlotinib—pancreatic cancer	0.000577	0.00495	CcSEcCtD
Praziquantel—Body temperature increased—Erlotinib—pancreatic cancer	0.000577	0.00495	CcSEcCtD
Praziquantel—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.000577	0.00495	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000576	0.00494	CcSEcCtD
Praziquantel—Malaise—Irinotecan—pancreatic cancer	0.000575	0.00493	CcSEcCtD
Praziquantel—Vertigo—Irinotecan—pancreatic cancer	0.000573	0.00492	CcSEcCtD
Praziquantel—Malaise—Gemcitabine—pancreatic cancer	0.00056	0.00481	CcSEcCtD
Praziquantel—Decreased appetite—Sunitinib—pancreatic cancer	0.000549	0.00471	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000546	0.00468	CcSEcCtD
Praziquantel—Fatigue—Sunitinib—pancreatic cancer	0.000545	0.00467	CcSEcCtD
Praziquantel—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000544	0.00466	CcSEcCtD
Praziquantel—Discomfort—Irinotecan—pancreatic cancer	0.000537	0.0046	CcSEcCtD
Praziquantel—Asthenia—Tamoxifen—pancreatic cancer	0.000529	0.00454	CcSEcCtD
Praziquantel—Convulsion—Fluorouracil—pancreatic cancer	0.000529	0.00454	CcSEcCtD
Praziquantel—Myalgia—Gemcitabine—pancreatic cancer	0.000529	0.00454	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000525	0.00451	CcSEcCtD
Praziquantel—Asthenia—Erlotinib—pancreatic cancer	0.000524	0.00449	CcSEcCtD
Praziquantel—Discomfort—Gemcitabine—pancreatic cancer	0.000523	0.00448	CcSEcCtD
Praziquantel—Pruritus—Tamoxifen—pancreatic cancer	0.000522	0.00448	CcSEcCtD
Praziquantel—Myalgia—Fluorouracil—pancreatic cancer	0.00052	0.00446	CcSEcCtD
Praziquantel—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000517	0.00443	CcSEcCtD
Praziquantel—Pruritus—Erlotinib—pancreatic cancer	0.000517	0.00443	CcSEcCtD
Praziquantel—Discomfort—Fluorouracil—pancreatic cancer	0.000514	0.00441	CcSEcCtD
Praziquantel—Nervous system disorder—Irinotecan—pancreatic cancer	0.000511	0.00438	CcSEcCtD
Praziquantel—Diarrhoea—Tamoxifen—pancreatic cancer	0.000505	0.00433	CcSEcCtD
Praziquantel—Body temperature increased—Sunitinib—pancreatic cancer	0.0005	0.00429	CcSEcCtD
Praziquantel—Abdominal pain—Sunitinib—pancreatic cancer	0.0005	0.00429	CcSEcCtD
Praziquantel—Diarrhoea—Erlotinib—pancreatic cancer	0.0005	0.00429	CcSEcCtD
Praziquantel—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000497	0.00427	CcSEcCtD
Praziquantel—Anorexia—Irinotecan—pancreatic cancer	0.000496	0.00426	CcSEcCtD
Praziquantel—Skin disorder—Gemcitabine—pancreatic cancer	0.000493	0.00423	CcSEcCtD
Praziquantel—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000489	0.00419	CcSEcCtD
Praziquantel—Dizziness—Tamoxifen—pancreatic cancer	0.000488	0.00419	CcSEcCtD
Praziquantel—Anorexia—Gemcitabine—pancreatic cancer	0.000483	0.00415	CcSEcCtD
Praziquantel—Dizziness—Erlotinib—pancreatic cancer	0.000483	0.00414	CcSEcCtD
Praziquantel—Anorexia—Fluorouracil—pancreatic cancer	0.000475	0.00408	CcSEcCtD
Praziquantel—Cardiac disorder—Docetaxel—pancreatic cancer	0.00047	0.00403	CcSEcCtD
Praziquantel—Vomiting—Tamoxifen—pancreatic cancer	0.000469	0.00402	CcSEcCtD
Praziquantel—Hypersensitivity—Sunitinib—pancreatic cancer	0.000466	0.00399	CcSEcCtD
Praziquantel—Rash—Tamoxifen—pancreatic cancer	0.000465	0.00399	CcSEcCtD
Praziquantel—Dermatitis—Tamoxifen—pancreatic cancer	0.000465	0.00399	CcSEcCtD
Praziquantel—Vomiting—Erlotinib—pancreatic cancer	0.000464	0.00398	CcSEcCtD
Praziquantel—Somnolence—Irinotecan—pancreatic cancer	0.000463	0.00397	CcSEcCtD
Praziquantel—Headache—Tamoxifen—pancreatic cancer	0.000462	0.00397	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000462	0.00396	CcSEcCtD
Praziquantel—Rash—Erlotinib—pancreatic cancer	0.00046	0.00395	CcSEcCtD
Praziquantel—Dermatitis—Erlotinib—pancreatic cancer	0.00046	0.00395	CcSEcCtD
Praziquantel—Immune system disorder—Docetaxel—pancreatic cancer	0.000458	0.00393	CcSEcCtD
Praziquantel—Headache—Erlotinib—pancreatic cancer	0.000457	0.00392	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000454	0.0039	CcSEcCtD
Praziquantel—Asthenia—Sunitinib—pancreatic cancer	0.000453	0.00389	CcSEcCtD
Praziquantel—Decreased appetite—Irinotecan—pancreatic cancer	0.000453	0.00388	CcSEcCtD
Praziquantel—Arrhythmia—Docetaxel—pancreatic cancer	0.000453	0.00388	CcSEcCtD
Praziquantel—Somnolence—Gemcitabine—pancreatic cancer	0.000451	0.00387	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000449	0.00386	CcSEcCtD
Praziquantel—Fatigue—Irinotecan—pancreatic cancer	0.000449	0.00385	CcSEcCtD
Praziquantel—Pruritus—Sunitinib—pancreatic cancer	0.000447	0.00384	CcSEcCtD
Praziquantel—Somnolence—Fluorouracil—pancreatic cancer	0.000443	0.0038	CcSEcCtD
Praziquantel—Decreased appetite—Gemcitabine—pancreatic cancer	0.000441	0.00378	CcSEcCtD
Praziquantel—Nausea—Tamoxifen—pancreatic cancer	0.000438	0.00376	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000438	0.00376	CcSEcCtD
Praziquantel—Fatigue—Gemcitabine—pancreatic cancer	0.000437	0.00375	CcSEcCtD
Praziquantel—Nausea—Erlotinib—pancreatic cancer	0.000434	0.00372	CcSEcCtD
Praziquantel—Decreased appetite—Fluorouracil—pancreatic cancer	0.000433	0.00372	CcSEcCtD
Praziquantel—Diarrhoea—Sunitinib—pancreatic cancer	0.000432	0.00371	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00043	0.00369	CcSEcCtD
Praziquantel—Feeling abnormal—Irinotecan—pancreatic cancer	0.000429	0.00368	CcSEcCtD
Praziquantel—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000426	0.00365	CcSEcCtD
Praziquantel—Eosinophilia—Epirubicin—pancreatic cancer	0.000423	0.00363	CcSEcCtD
Praziquantel—Dizziness—Sunitinib—pancreatic cancer	0.000418	0.00359	CcSEcCtD
Praziquantel—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000418	0.00358	CcSEcCtD
Praziquantel—Abdominal pain—Irinotecan—pancreatic cancer	0.000412	0.00353	CcSEcCtD
Praziquantel—Body temperature increased—Irinotecan—pancreatic cancer	0.000412	0.00353	CcSEcCtD
Praziquantel—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000411	0.00352	CcSEcCtD
Praziquantel—Vomiting—Sunitinib—pancreatic cancer	0.000402	0.00345	CcSEcCtD
Praziquantel—Body temperature increased—Gemcitabine—pancreatic cancer	0.000401	0.00344	CcSEcCtD
Praziquantel—Rash—Sunitinib—pancreatic cancer	0.000398	0.00342	CcSEcCtD
Praziquantel—Dermatitis—Sunitinib—pancreatic cancer	0.000398	0.00342	CcSEcCtD
Praziquantel—Urticaria—Fluorouracil—pancreatic cancer	0.000396	0.0034	CcSEcCtD
Praziquantel—Headache—Sunitinib—pancreatic cancer	0.000396	0.0034	CcSEcCtD
Praziquantel—Body temperature increased—Fluorouracil—pancreatic cancer	0.000394	0.00338	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—pancreatic cancer	0.000391	0.00335	CcSEcCtD
Praziquantel—Hypersensitivity—Irinotecan—pancreatic cancer	0.000384	0.00329	CcSEcCtD
Praziquantel—Convulsion—Docetaxel—pancreatic cancer	0.000382	0.00328	CcSEcCtD
Praziquantel—Drowsiness—Epirubicin—pancreatic cancer	0.000381	0.00326	CcSEcCtD
Praziquantel—Myalgia—Docetaxel—pancreatic cancer	0.000375	0.00322	CcSEcCtD
Praziquantel—Nausea—Sunitinib—pancreatic cancer	0.000375	0.00322	CcSEcCtD
Praziquantel—Asthenia—Irinotecan—pancreatic cancer	0.000374	0.0032	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000373	0.0032	CcSEcCtD
Praziquantel—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000367	0.00315	CcSEcCtD
Praziquantel—Asthenia—Gemcitabine—pancreatic cancer	0.000364	0.00312	CcSEcCtD
Praziquantel—Pruritus—Gemcitabine—pancreatic cancer	0.000359	0.00308	CcSEcCtD
Praziquantel—Diarrhoea—Irinotecan—pancreatic cancer	0.000356	0.00306	CcSEcCtD
Praziquantel—Nervous system disorder—Docetaxel—pancreatic cancer	0.000353	0.00303	CcSEcCtD
Praziquantel—Pruritus—Fluorouracil—pancreatic cancer	0.000353	0.00303	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—pancreatic cancer	0.000352	0.00302	CcSEcCtD
Praziquantel—Skin disorder—Docetaxel—pancreatic cancer	0.00035	0.003	CcSEcCtD
Praziquantel—Bradycardia—Epirubicin—pancreatic cancer	0.000348	0.00298	CcSEcCtD
Praziquantel—Diarrhoea—Gemcitabine—pancreatic cancer	0.000347	0.00298	CcSEcCtD
Praziquantel—Dizziness—Irinotecan—pancreatic cancer	0.000344	0.00295	CcSEcCtD
Praziquantel—Anorexia—Docetaxel—pancreatic cancer	0.000343	0.00294	CcSEcCtD
Praziquantel—Diarrhoea—Fluorouracil—pancreatic cancer	0.000341	0.00293	CcSEcCtD
Praziquantel—Vomiting—Irinotecan—pancreatic cancer	0.000331	0.00284	CcSEcCtD
Praziquantel—Dizziness—Fluorouracil—pancreatic cancer	0.00033	0.00283	CcSEcCtD
Praziquantel—Rash—Irinotecan—pancreatic cancer	0.000328	0.00282	CcSEcCtD
Praziquantel—Dermatitis—Irinotecan—pancreatic cancer	0.000328	0.00281	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000328	0.00281	CcSEcCtD
Praziquantel—Headache—Irinotecan—pancreatic cancer	0.000326	0.0028	CcSEcCtD
Praziquantel—Vomiting—Gemcitabine—pancreatic cancer	0.000322	0.00277	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—pancreatic cancer	0.000322	0.00276	CcSEcCtD
Praziquantel—Somnolence—Docetaxel—pancreatic cancer	0.00032	0.00274	CcSEcCtD
Praziquantel—Rash—Gemcitabine—pancreatic cancer	0.00032	0.00274	CcSEcCtD
Praziquantel—Dermatitis—Gemcitabine—pancreatic cancer	0.000319	0.00274	CcSEcCtD
Praziquantel—Headache—Gemcitabine—pancreatic cancer	0.000318	0.00273	CcSEcCtD
Praziquantel—Cardiac disorder—Epirubicin—pancreatic cancer	0.000317	0.00272	CcSEcCtD
Praziquantel—Vomiting—Fluorouracil—pancreatic cancer	0.000317	0.00272	CcSEcCtD
Praziquantel—Rash—Fluorouracil—pancreatic cancer	0.000314	0.0027	CcSEcCtD
Praziquantel—Dermatitis—Fluorouracil—pancreatic cancer	0.000314	0.00269	CcSEcCtD
Praziquantel—Decreased appetite—Docetaxel—pancreatic cancer	0.000313	0.00268	CcSEcCtD
Praziquantel—Headache—Fluorouracil—pancreatic cancer	0.000312	0.00268	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000311	0.00267	CcSEcCtD
Praziquantel—Fatigue—Docetaxel—pancreatic cancer	0.00031	0.00266	CcSEcCtD
Praziquantel—Nausea—Irinotecan—pancreatic cancer	0.000309	0.00265	CcSEcCtD
Praziquantel—Immune system disorder—Epirubicin—pancreatic cancer	0.000309	0.00265	CcSEcCtD
Praziquantel—Arrhythmia—Epirubicin—pancreatic cancer	0.000305	0.00262	CcSEcCtD
Praziquantel—Nausea—Gemcitabine—pancreatic cancer	0.000301	0.00258	CcSEcCtD
Praziquantel—Feeling abnormal—Docetaxel—pancreatic cancer	0.000297	0.00254	CcSEcCtD
Praziquantel—Nausea—Fluorouracil—pancreatic cancer	0.000296	0.00254	CcSEcCtD
Praziquantel—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000294	0.00252	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000293	0.00252	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—pancreatic cancer	0.000286	0.00245	CcSEcCtD
Praziquantel—Abdominal pain—Docetaxel—pancreatic cancer	0.000284	0.00244	CcSEcCtD
Praziquantel—Body temperature increased—Docetaxel—pancreatic cancer	0.000284	0.00244	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—pancreatic cancer	0.000282	0.00242	CcSEcCtD
Praziquantel—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000276	0.00237	CcSEcCtD
Praziquantel—Malaise—Epirubicin—pancreatic cancer	0.000268	0.0023	CcSEcCtD
Praziquantel—Vertigo—Epirubicin—pancreatic cancer	0.000267	0.00229	CcSEcCtD
Praziquantel—Hypersensitivity—Docetaxel—pancreatic cancer	0.000265	0.00227	CcSEcCtD
Praziquantel—Asthenia—Docetaxel—pancreatic cancer	0.000258	0.00222	CcSEcCtD
Praziquantel—Convulsion—Epirubicin—pancreatic cancer	0.000258	0.00221	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000255	0.00219	CcSEcCtD
Praziquantel—Pruritus—Docetaxel—pancreatic cancer	0.000255	0.00218	CcSEcCtD
Praziquantel—Myalgia—Epirubicin—pancreatic cancer	0.000253	0.00217	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000251	0.00216	CcSEcCtD
Praziquantel—Discomfort—Epirubicin—pancreatic cancer	0.00025	0.00215	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—pancreatic cancer	0.000248	0.00213	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—pancreatic cancer	0.000247	0.00212	CcSEcCtD
Praziquantel—Diarrhoea—Docetaxel—pancreatic cancer	0.000246	0.00211	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—pancreatic cancer	0.000238	0.00205	CcSEcCtD
Praziquantel—Nervous system disorder—Epirubicin—pancreatic cancer	0.000238	0.00204	CcSEcCtD
Praziquantel—Dizziness—Docetaxel—pancreatic cancer	0.000238	0.00204	CcSEcCtD
Praziquantel—Skin disorder—Epirubicin—pancreatic cancer	0.000236	0.00202	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—pancreatic cancer	0.000234	0.00201	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000233	0.002	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—pancreatic cancer	0.000231	0.00199	CcSEcCtD
Praziquantel—Anorexia—Epirubicin—pancreatic cancer	0.000231	0.00198	CcSEcCtD
Praziquantel—Vomiting—Docetaxel—pancreatic cancer	0.000229	0.00196	CcSEcCtD
Praziquantel—Rash—Docetaxel—pancreatic cancer	0.000227	0.00195	CcSEcCtD
Praziquantel—Dermatitis—Docetaxel—pancreatic cancer	0.000227	0.00194	CcSEcCtD
Praziquantel—Headache—Docetaxel—pancreatic cancer	0.000225	0.00193	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000221	0.0019	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00022	0.00189	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—pancreatic cancer	0.000218	0.00187	CcSEcCtD
Praziquantel—Somnolence—Epirubicin—pancreatic cancer	0.000216	0.00185	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—pancreatic cancer	0.000214	0.00184	CcSEcCtD
Praziquantel—Nausea—Docetaxel—pancreatic cancer	0.000214	0.00183	CcSEcCtD
Praziquantel—Decreased appetite—Epirubicin—pancreatic cancer	0.000211	0.00181	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00021	0.0018	CcSEcCtD
Praziquantel—Fatigue—Epirubicin—pancreatic cancer	0.000209	0.0018	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000205	0.00176	CcSEcCtD
Praziquantel—Feeling abnormal—Epirubicin—pancreatic cancer	0.0002	0.00172	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—pancreatic cancer	0.0002	0.00171	CcSEcCtD
Praziquantel—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000198	0.0017	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—pancreatic cancer	0.000195	0.00167	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000194	0.00166	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—pancreatic cancer	0.000194	0.00166	CcSEcCtD
Praziquantel—Urticaria—Epirubicin—pancreatic cancer	0.000193	0.00165	CcSEcCtD
Praziquantel—Body temperature increased—Epirubicin—pancreatic cancer	0.000192	0.00165	CcSEcCtD
Praziquantel—Abdominal pain—Epirubicin—pancreatic cancer	0.000192	0.00165	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000185	0.00159	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000184	0.00158	CcSEcCtD
Praziquantel—Hypersensitivity—Epirubicin—pancreatic cancer	0.000179	0.00153	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—pancreatic cancer	0.000178	0.00153	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—pancreatic cancer	0.000178	0.00152	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—pancreatic cancer	0.000178	0.00152	CcSEcCtD
Praziquantel—Asthenia—Epirubicin—pancreatic cancer	0.000174	0.00149	CcSEcCtD
Praziquantel—Pruritus—Epirubicin—pancreatic cancer	0.000172	0.00147	CcSEcCtD
Praziquantel—Diarrhoea—Epirubicin—pancreatic cancer	0.000166	0.00142	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000165	0.00142	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—pancreatic cancer	0.000161	0.00138	CcSEcCtD
Praziquantel—Dizziness—Epirubicin—pancreatic cancer	0.000161	0.00138	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—pancreatic cancer	0.000159	0.00136	CcSEcCtD
Praziquantel—Vomiting—Epirubicin—pancreatic cancer	0.000154	0.00132	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—pancreatic cancer	0.000154	0.00132	CcSEcCtD
Praziquantel—Rash—Epirubicin—pancreatic cancer	0.000153	0.00131	CcSEcCtD
Praziquantel—Dermatitis—Epirubicin—pancreatic cancer	0.000153	0.00131	CcSEcCtD
Praziquantel—Headache—Epirubicin—pancreatic cancer	0.000152	0.0013	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—pancreatic cancer	0.000149	0.00127	CcSEcCtD
Praziquantel—Nausea—Epirubicin—pancreatic cancer	0.000144	0.00124	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—pancreatic cancer	0.000143	0.00123	CcSEcCtD
Praziquantel—Rash—Doxorubicin—pancreatic cancer	0.000142	0.00121	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—pancreatic cancer	0.000141	0.00121	CcSEcCtD
Praziquantel—Headache—Doxorubicin—pancreatic cancer	0.000141	0.00121	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—pancreatic cancer	0.000133	0.00114	CcSEcCtD
